DNAM-1 Antibodies

Santa Cruz Biotechnology delivers a wide array of DNAM-1 monoclonal antibodies for research focused on understanding immune responses. DNAM-1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DNAM-1, or DNAX accessory molecule-1, functions as a crucial receptor involved in the activation of T cells and natural killer (NK) cells, playing a significant role in the immune system's ability to recognize and eliminate tumor cells and infected cells. DNAM-1 expression levels significantly influence the effectiveness of immunotherapies. Research into DNAM-1 mechanisms continues to reveal potential therapeutic strategies for cancer and infectious diseases. Investigating DNAM-1 pathways helps researchers understand immune system regulation and response patterns. Advanced research techniques using DNAM-1 monoclonal antibodies enable detailed analysis of cellular interactions and signaling pathways. Current studies focusing on DNAM-1 are uncovering new possibilities in immunotherapy development. Santa Cruz Biotechnology monoclonal antibodies for DNAM-1 support researchers worldwide in advancing our understanding of immune system function and potential therapeutic applications.